SonALAsense

📍 Oakland, United States👥 12 employees💰 Last funded Nov 2024
Biotechnology Research🌐 sonalasense.com
Website LinkedIn
SonALAsense is a clinical-stage company developing ALA sonodynamic therapy (SDT) as a first-in-class, non-invasive drug-device combination for the treatment of recurrent glioblastoma multiforme (rGBM) and other deadly cancers. SDT utilizes MRI-guided focused ultrasound (the device) in combination with aminolevulinic acid (a drug) to selectively target and kill tumor cells.
2
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
United Kingdom
1
United States
1
Frequently asked questions
Who invested in SonALAsense?
SonALAsense has 2 investors on record on gritt.io.
When did SonALAsense last raise funding?
The most recent investment in SonALAsense recorded on gritt.io was in November 2024.
What industry is SonALAsense in?
SonALAsense operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is SonALAsense based?
SonALAsense is headquartered in Oakland, United States.